223 related articles for article (PubMed ID: 30370976)
21. Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis.
Schiattarella GG; Sannino A; Toscano E; Giugliano G; Gargiulo G; Franzone A; Trimarco B; Esposito G; Perrino C
Eur Heart J; 2017 Oct; 38(39):2948-2956. PubMed ID: 29020409
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease.
Morrow DA; de Lemos JA; Blazing MA; Sabatine MS; Murphy SA; Jarolim P; White HD; Fox KA; Califf RM; Braunwald E;
JAMA; 2005 Dec; 294(22):2866-71. PubMed ID: 16352794
[TBL] [Abstract][Full Text] [Related]
23. The correlation between plasma trimethylamine N-oxide level and heart failure classification in northern Chinese patients.
Dong Z; Liang Z; Wang X; Liu W; Zhao L; Wang S; Hai X; Yu K
Ann Palliat Med; 2020 Sep; 9(5):2862-2871. PubMed ID: 32921087
[TBL] [Abstract][Full Text] [Related]
24. Microbiota-derived Trimethylamine N-oxide Predicts Cardiovascular Risk After STEMI.
Matsuzawa Y; Nakahashi H; Konishi M; Sato R; Kawashima C; Kikuchi S; Akiyama E; Iwahashi N; Maejima N; Okada K; Ebina T; Hibi K; Kosuge M; Ishigami T; Tamura K; Kimura K
Sci Rep; 2019 Aug; 9(1):11647. PubMed ID: 31406181
[TBL] [Abstract][Full Text] [Related]
25. B-type natriuretic peptide-guided therapy for heart failure (HF): a systematic review and meta-analysis of individual participant data (IPD) and aggregate data.
Pufulete M; Maishman R; Dabner L; Higgins JPT; Rogers CA; Dayer M; MacLeod J; Purdy S; Hollingworth W; Schou M; Anguita-Sanchez M; Karlström P; Shochat MK; McDonagh T; Nightingale AK; Reeves BC
Syst Rev; 2018 Jul; 7(1):112. PubMed ID: 30064502
[TBL] [Abstract][Full Text] [Related]
26. Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events.
Kim RB; Morse BL; Djurdjev O; Tang M; Muirhead N; Barrett B; Holmes DT; Madore F; Clase CM; Rigatto C; Levin A;
Kidney Int; 2016 May; 89(5):1144-1152. PubMed ID: 27083288
[TBL] [Abstract][Full Text] [Related]
27. Trimethylamine
Stubbs JR; Stedman MR; Liu S; Long J; Franchetti Y; West RE; Prokopienko AJ; Mahnken JD; Chertow GM; Nolin TD
Clin J Am Soc Nephrol; 2019 Feb; 14(2):261-267. PubMed ID: 30665924
[TBL] [Abstract][Full Text] [Related]
28. Clinical Role of CA125 in Worsening Heart Failure: A BIOSTAT-CHF Study Subanalysis.
Núñez J; Bayés-Genís A; Revuelta-López E; Ter Maaten JM; Miñana G; Barallat J; Cserkóová A; Bodi V; Fernández-Cisnal A; Núñez E; Sanchis J; Lang C; Ng LL; Metra M; Voors AA
JACC Heart Fail; 2020 May; 8(5):386-397. PubMed ID: 32171764
[TBL] [Abstract][Full Text] [Related]
29. Worsening Renal Function during Management for Chronic Heart Failure with Reduced Ejection Fraction: Results From the Pro-BNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.
Ibrahim NE; Gaggin HK; Rabideau DJ; Gandhi PU; Mallick A; Januzzi JL
J Card Fail; 2017 Feb; 23(2):121-130. PubMed ID: 27469482
[TBL] [Abstract][Full Text] [Related]
30. The heart and gut relationship: a systematic review of the evaluation of the microbiome and trimethylamine-N-oxide (TMAO) in heart failure.
Anderson KM; Ferranti EP; Alagha EC; Mykityshyn E; French CE; Reilly CM
Heart Fail Rev; 2022 Nov; 27(6):2223-2249. PubMed ID: 35726110
[TBL] [Abstract][Full Text] [Related]
31. Trimethylamine-
Zheng Y; Tang Z; You L; Wu Y; Liu J; Xue J
Ren Fail; 2020 Nov; 42(1):580-586. PubMed ID: 32576072
[No Abstract] [Full Text] [Related]
32. Trimethylamine N-oxide and Risk Stratification after Acute Myocardial Infarction.
Suzuki T; Heaney LM; Jones DJ; Ng LL
Clin Chem; 2017 Jan; 63(1):420-428. PubMed ID: 28062632
[TBL] [Abstract][Full Text] [Related]
33. Long-Term Changes in Gut Microbial Metabolite Trimethylamine N-Oxide and Coronary Heart Disease Risk.
Heianza Y; Ma W; DiDonato JA; Sun Q; Rimm EB; Hu FB; Rexrode KM; Manson JE; Qi L
J Am Coll Cardiol; 2020 Feb; 75(7):763-772. PubMed ID: 32081286
[TBL] [Abstract][Full Text] [Related]
34. Responder to BNP-guided treatment in heart failure. The process of defining a responder.
Karlström P; Dahlström U; Boman K; Alehagen U
Scand Cardiovasc J; 2015; 49(6):316-24. PubMed ID: 26153427
[TBL] [Abstract][Full Text] [Related]
35. BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.
Pfisterer M; Buser P; Rickli H; Gutmann M; Erne P; Rickenbacher P; Vuillomenet A; Jeker U; Dubach P; Beer H; Yoon SI; Suter T; Osterhues HH; Schieber MM; Hilti P; Schindler R; Brunner-La Rocca HP;
JAMA; 2009 Jan; 301(4):383-92. PubMed ID: 19176440
[TBL] [Abstract][Full Text] [Related]
36. Geographical location affects the levels and association of trimethylamine N-oxide with heart failure mortality in BIOSTAT-CHF: a post-hoc analysis.
Yazaki Y; Salzano A; Nelson CP; Voors AA; Anker SD; Cleland JG; Lang CC; Metra M; Samani NJ; Ng LL; Suzuki T
Eur J Heart Fail; 2019 Oct; 21(10):1291-1294. PubMed ID: 31353762
[No Abstract] [Full Text] [Related]
37. Heart Failure Disturbs Gut-Blood Barrier and Increases Plasma Trimethylamine, a Toxic Bacterial Metabolite.
Drapala A; Szudzik M; Chabowski D; Mogilnicka I; Jaworska K; Kraszewska K; Samborowska E; Ufnal M
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32859047
[TBL] [Abstract][Full Text] [Related]
38. Trimethylamine N-oxide is associated with long-term mortality risk: the multi-ethnic study of atherosclerosis.
Wang M; Li XS; Wang Z; de Oliveira Otto MC; Lemaitre RN; Fretts A; Sotoodehnia N; Budoff M; Nemet I; DiDonato JA; Tang WHW; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
Eur Heart J; 2023 May; 44(18):1608-1618. PubMed ID: 36883587
[TBL] [Abstract][Full Text] [Related]
39. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.
Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL
Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331
[TBL] [Abstract][Full Text] [Related]
40. Association of Circulating Trimethylamine
Flores-Guerrero JL; Osté MCJ; Baraldi PB; Connelly MA; Garcia E; Navis G; Bakker SJL; Dullaart RPF
Nutrients; 2021 Jan; 13(1):. PubMed ID: 33477634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
